February 16, 2021
Recapitulating the Multifaceted Inflammatory Environment of the Intestine In Vitro
Intestinal inflammatory diseases are highly complex, which has thus far prevented development of an effective in vitro disease model. With access to a donor-derived cell biobank and the ability to recapitulate region-specific environments of the intestine, Altis Biosystems is working toward the development of an in vitro RepliGut® model to accurately recapitulate the complex intestinal inflammatory microenvironments.
December 23, 2020
How Does Altis Biosystems Envision the Future of the Pharma/Biopharma Industry?
How Does Altis Biosystems Envision the Future of the Pharma/Biopharma Industry?
November 30, 2020
Enhancing Human Gut Tissue Models through Gene Editing
Enhancing Human Gut Tissue Models through Gene Editing
November 10, 2020
Increasing the Efficiency of Drug Development With Preclinical Testing Using Human Intestinal Stem Cells
Increasing the Efficiency of Drug Development with Preclinical Testing Using Human Intestinal Stem Cells
October 23, 2020
Characterization of a Novel Human Primary Intestinal Epithelial Monolayer Platform in Response to Cytokine Challenge (Poster)
The ability to grow and expend primary human epithelial cells in vitro has been a significant advancement in the field of gastrointestinal biology. The ALTIS RepliGut® Planar system uses a proprietary biomimetic scaffold on a porous membrane to form a human intestinal epithelial monolayer...